Previous 10 | Next 10 |
Ortho Clinical Diagnostics (OCDX) announces the launch of its quantitative COVID-19 IgG antibody test in addition to a total COVID-19 nucleocapsid antibody test.Both tests help in differentiating the cause of antibodies against SARS-CoV-2 and are processed on Ortho's VITROS Sys...
Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response Canada NewsWire - Ortho is the only company that offers laboratories in the U...
RARITAN, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to present in two upcoming investor conferences: ...
The FDA has issued a safety announcement that the public should not use the results of SARS-CoV-2 antibody tests to determine immunity or protection against COVID-19.The tests should only be used to determine if someone has been exposed to SARS-CoV-2 in the past and developed an immune respon...
Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive Authorization by Health Canada Canada NewsWire - Ortho's VITROS ® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen te...
Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2021 Earnings Conference Call May 05, 2021, 05:00 PM ET Company Participants John Sanders - VP of Finance, Treasurer, and Head of IR Chris Smith - Chairman and CEO Joe Busky - CFO Mike Iskra - EVP, Commercial Excellence and Strategy Conference...
The following slide deck was published by Ortho Clinical Diagnostics Holdings plc in conjunction with their 2021 Q1 earnings call. For further details see: Ortho Clinical Diagnostics Holdings plc 2021 Q1 - Results - Earnings Call Presentation
Image source: The Motley Fool. Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) Q1 2021 Earnings Call May 05, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2...
Ortho Clinical Diagnostics (OCDX): Q1 Non-GAAP EPS of $0.26 beats by $0.10; GAAP EPS of -$0.19 beats by $0.09.Revenue of $499.3M (+23.5% Y/Y) beats by $21.77M.Press Release For further details see: Ortho Clinical Diagnostics EPS beats by $0.10, beats on revenue
RARITAN, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in-vitro diagnostics (IVD) companies, today announced financial results for the first quarter ended April 4, 2021. Highlights Firs...
News, Short Squeeze, Breakout and More Instantly...
Ortho Clinical Diagnostics plc Company Name:
OCDX Stock Symbol:
NASDAQ Market:
Ortho Clinical Diagnostics plc Website:
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc (“Ortho”), one of the world’s larger pure-p...
RARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho” or the “Company”), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that based on a preliminary vote c...
Image source: The Motley Fool. Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) Q1 2022 Earnings Call May 04, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2...